[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335003-105":59,"doc-detail-335003-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-fbp1-expression-by-kmt5a-through-twist1-methylation-is-one-of-the-mechanisms-leading-to-chemoresistance-in-breast-cancer","Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer","","Lysine methyltransferase 5A (KMT5A) catalyzes mono-methylation of histone H4 lysine 20 and non-histone substrates, and it has been implicated in cancer progression. This study evaluated how KMT5A promotes docetaxel (DTX) resistance in breast carcinoma by analyzing glucose metabolism and the underlying signaling mechanism. KMT5A knockdown in breast cancer cells followed Tandem Mass Tag proteomics, revealing increased fructose-1,6-bisphosphatase 1 (FBP1), a gluconeogenic enzyme linked to cancer development and outcome. Dual-luciferase assays and functional overexpression showed KMT5A suppressed FBP1 to enhance DTX sensitivity, while the KMT5A inhibitor UNC0379 confirmed methylase-dependent regulation via TWIST1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-fbp1-expression-by-kmt5a-through-twist1-methylation-is-one-of-the-mechanisms-leading-to-chemoresistance-in-breast-cancer/335003/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-fbp1-expression-by-kmt5a-through-twist1-methylation-is-one-of-the-mechanisms-leading-to-chemoresistance-in-breast-cancer/335003.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study in breast cancer?","Question",{"text":112,"@type":113},"To determine how KMT5A drives docetaxel (DTX) resistance in breast carcinoma by examining glucose metabolism and identifying the underlying mechanism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers identify key proteins involved?",{"text":117,"@type":113},"After KMT5A knockdown in breast cancer cells, tandem mass tag proteomics was used to evaluate differential protein expression and pathway enrichment, leading to the discovery of upregulated FBP1.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does TWIST1 methylation play according to the findings?",{"text":121,"@type":113},"The study reports that KMT5A inhibits FBP1 expression by methylating TWIST1 and weakening TWIST1-mediated promotion of FBP1 transcription.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335003,1790640395,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","ONCOLOGY REPORTS 52: 110, 2024  \nInhibition ofFBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer  \n* * *  \nXUE PENG , LISI MA , XUAN CHEN , FEN TANG and XIANGYUN ZONG  \nDepartment of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, P.R. China  \nReceived March 4, 2024; Accepted May 31, 2024  \nDOI: 10. 3892/or.2024.8769  \nAbstract. Lysine methyltransferase 5A (KMT5A) is the sole mammalian enzyme known to catalyse the mono‑methylation of histone H4 lysine 20 and non‑histone proteins such asp53, which are involved in the occurrence and progression of numerous cancers. The present study aimed to determine the function ofKMT5A in inducing docetaxel (DTX) resistance inpatients with breast carcinoma by evaluating glucose metabo‑ lism and the underlying mechanism involved. The upregulation or downregulation of KMT5A‑related proteins was examined after KMT5A knockdown in breast cancer (BRCA) cells by Tandem Mass Tag proteomics. Through differential protein expression and pathway enrichment analysis, the upregulated key gluconeogenic enzyme fructose‑1,6‑bisphosphatase 1 (FBP1) was discovered. Loss of FBP1 expression is closely related to the development and prognosis of cancers . A dual‑luciferase reporter gene assay confirmed that KMT5A inhibited the expression of FBP1 and that overexpression of FBP1 could enhance the chemotherapeutic sensitivity to DTX through the suppression of KMT5A expression . The KMT5A inhibitor UNC0379 was used to verify that DTX resistance induced by KMT5A through the inhibition of FBP1 depended on the methylase activity of KMT5A. According to previous literature and interaction network structure, it was  \nCorrespondence to: Dr Xiangyun Zong, Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai 200233, P.R. China  \nE‑mail: [tigerzong@msn.com](tigerzong@msn.com)  \n*Contributed equally  \nAbbreviations: BRCA, breast cancer; DTX, docetaxel; FBP1, fructose‑1,6‑bisphosphatase; IC50, half maximal inhibitory concentration; KMT5A, lysine methyltransferase 5A; RT‑qPCR, reverse transcription‑quantitative polymerase chain reaction  \nKey words: KMT5A, glucose metabolism, chemoresistance, BRCA, FBP1  \nrevealed that KMT5A acts on the transcription factor twist family BHLH transcription factor 1 (TWIST1) . Then, it was verified that TWSIT1 promoted the expression of FBP1 by using a dual‑luciferase reporter gene experiment. KMT5A induces chemotherapy resistance in BRCA cells by promoting cell proliferation and glycolysis. After the knockdown of the KMT5A gene, the FBP1 related to glucose metabolism in BRCA was upregulated. KMT5A knockdown expression and FBP1 overexpression synergistically inhibit cell prolifera‑ tion and block cells in the G2/M phase. KMT5A inhibits the expression of FBP1 by methylating TWIST1 and weakening its promotion of FBP1 transcription. In conclusion, KMT5A was shown to affect chemotherapy resistance by regulating the cell cycle and positively regulate glycolysis‑mediated chemo‑ therapy resistance by inhibiting the transcription of FBP1 in collaboration with TWIST1 . KMT5A may be a potential therapeutic target for chemotherapy resistance in BRCA.  \nIntroduction  \nChemotherapy, as a comprehensive treatment for breast cancer (BRCA), has improved the survival rate of patients with BRCA, to a certain extent (1) . Docetaxel (DTX), a semisyn‑ thetic derivative of paclitaxel, is a second‑generation paclitaxel anticancer drug and serves as the cornerstone of various BRCA chemotherapy regimens (2). However, the occurrence of drug resistance has limited the clinical efficacy of taxanes to some extent (3). Congenital and acquired chemoresistance constitute important reasons for long‑term treatment failure in patients with BRCA (4) . The mechanisms of congenital resistan","cbCaii03zTkHI8P7","https://ap.wps.com/l/cbCaii03zTkHI8P7","pdf",7529426,13,"English","# Abstract\n# Introduction\n# Background and Rationale\n## KMT5A and SETD8/SET8 function\n## FBP1 and glucose metabolism\n## Chemoresistance in breast cancer\n# Methods Overview\n## KMT5A knockdown and proteomics\n## DTX sensitivity assessment\n## Mechanistic validation using reporter assays","[{\"question\":\"What is the main purpose of this study in breast cancer?\",\"answer\":\"To determine how KMT5A drives docetaxel (DTX) resistance in breast carcinoma by examining glucose metabolism and identifying the underlying mechanism.\"},{\"question\":\"How did the researchers identify key proteins involved?\",\"answer\":\"After KMT5A knockdown in breast cancer cells, tandem mass tag proteomics was used to evaluate differential protein expression and pathway enrichment, leading to the discovery of upregulated FBP1.\"},{\"question\":\"What role does TWIST1 methylation play according to the findings?\",\"answer\":\"The study reports that KMT5A inhibits FBP1 expression by methylating TWIST1 and weakening TWIST1-mediated promotion of FBP1 transcription.\"}]","Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer | PDF",1790009186,33]